Investigator
Jeremy Purvis
UNIV OF NORTH CAROLINA CHAPEL HILL · funded by NCI, NIGMS
- Companies
- 1
- Grants
- 3
- Non-dilutive funding
- $2.5M
- First award
- Sep 11, 2020
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Feb 1, 2024.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- MiNDERA Corp57momentum
OncologyFormed
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Cell cycle paths as a framework for understanding drug resistance in tumor cell subpopulations
$622kFeb 1, 2024NCIUNIV OF NORTH CAROLINA CHAPEL HILLNIH RePORTER · 11012299 (opens the source filing in a new tab)
- R01
Cell cycle paths as a framework for understanding drug resistance in tumor cell subpopulations
$609kFeb 1, 2024NCIUNIV OF NORTH CAROLINA CHAPEL HILLNIH RePORTER · 11284085 (opens the source filing in a new tab)
- R01
Computational Models of the Human Cell Cycle to Reveal Disease Mechanism and Inform Treatment
$1.2MSep 11, 2020NIGMSUNIV OF NORTH CAROLINA CHAPEL HILLNIH RePORTER · 11168501 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources